Pawlaczyk Krzysztof, Baum Ewa, Schwermer Krzysztof, Hoppe Krzysztof, Lindholm Bengt, Breborowicz Andrzej
Department of Nephrology, Transplantology, and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland ; Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention, and Technology, Karolinska Institute, Stockholm, Sweden.
Department of Pathophysiology, Poznan University of Medical Sciences, Ulica Rokietnicka 8, 60-806 Poznan, Poland.
Biomed Res Int. 2015;2015:261813. doi: 10.1155/2015/261813. Epub 2015 Jul 6.
Experimental animal models improve our understanding of technical problems in peritoneal dialysis PD, and such studies contribute to solving crucial clinical problems. We established an acute and chronic PD model in nonuremic and uremic rats. We observed that kinetics of PD in rats change as the animals are aging, and this effect is due not only to an increasing peritoneal surface area, but also to changes in the permeability of the peritoneum. Changes of the peritoneal permeability seen during chronic PD in rats are comparable to results obtained in humans treated with PD. Effluent dialysate can be drained repeatedly to measure concentration of various bioactive molecules and to correlate the results with the peritoneal permeability. Additionally we can study in in vitro conditions properties of the effluent dialysate on cultured peritoneal mesothelial cells or fibroblasts. We can evaluate acute and chronic effect of various additives to the dialysis fluid on function and permeability of the peritoneum. Results from such study are even more relevant to the clinical scenario when experiments are performed in uremic rats. Our experimental animal PD model not only helps to understand the pathophysiology of PD but also can be used for testing biocompatibility of new PD fluids.
实验动物模型有助于我们理解腹膜透析(PD)中的技术问题,此类研究有助于解决关键的临床问题。我们在非尿毒症和尿毒症大鼠中建立了急性和慢性PD模型。我们观察到,随着大鼠年龄增长,其PD动力学发生变化,这种影响不仅归因于腹膜表面积增加,还归因于腹膜通透性的改变。大鼠慢性PD期间观察到的腹膜通透性变化与接受PD治疗的人类所获结果相当。可反复引流流出的透析液,以测量各种生物活性分子的浓度,并将结果与腹膜通透性相关联。此外,我们可以在体外条件下研究流出透析液对培养的腹膜间皮细胞或成纤维细胞的特性。我们可以评估透析液中各种添加剂对腹膜功能和通透性的急性和慢性影响。当在尿毒症大鼠中进行实验时,此类研究结果与临床情况更为相关。我们的实验动物PD模型不仅有助于理解PD的病理生理学,还可用于测试新型PD液的生物相容性。